EP1797455B1 - Adjustable tracing of flow velocities in doppler velocity spectra - Google Patents
Adjustable tracing of flow velocities in doppler velocity spectra Download PDFInfo
- Publication number
- EP1797455B1 EP1797455B1 EP20050776023 EP05776023A EP1797455B1 EP 1797455 B1 EP1797455 B1 EP 1797455B1 EP 20050776023 EP20050776023 EP 20050776023 EP 05776023 A EP05776023 A EP 05776023A EP 1797455 B1 EP1797455 B1 EP 1797455B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- trace
- display
- imaging system
- ultrasonic diagnostic
- diagnostic imaging
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000001228 spectrum Methods 0.000 title claims description 8
- 230000003595 spectral effect Effects 0.000 claims abstract description 72
- 238000002059 diagnostic imaging Methods 0.000 claims abstract description 16
- 238000004364 calculation method Methods 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims description 14
- 230000017531 blood circulation Effects 0.000 claims description 2
- 239000000700 radioactive tracer Substances 0.000 claims 1
- 238000002604 ultrasonography Methods 0.000 description 11
- 230000003205 diastolic effect Effects 0.000 description 5
- 238000002592 echocardiography Methods 0.000 description 5
- 239000003550 marker Substances 0.000 description 4
- 238000010586 diagram Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 210000003484 anatomy Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01S—RADIO DIRECTION-FINDING; RADIO NAVIGATION; DETERMINING DISTANCE OR VELOCITY BY USE OF RADIO WAVES; LOCATING OR PRESENCE-DETECTING BY USE OF THE REFLECTION OR RERADIATION OF RADIO WAVES; ANALOGOUS ARRANGEMENTS USING OTHER WAVES
- G01S7/00—Details of systems according to groups G01S13/00, G01S15/00, G01S17/00
- G01S7/52—Details of systems according to groups G01S13/00, G01S15/00, G01S17/00 of systems according to group G01S15/00
- G01S7/52017—Details of systems according to groups G01S13/00, G01S15/00, G01S17/00 of systems according to group G01S15/00 particularly adapted to short-range imaging
- G01S7/52053—Display arrangements
- G01S7/52057—Cathode ray tube displays
- G01S7/52073—Production of cursor lines, markers or indicia by electronic means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/06—Measuring blood flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/13—Tomography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/46—Ultrasonic, sonic or infrasonic diagnostic devices with special arrangements for interfacing with the operator or the patient
- A61B8/461—Displaying means of special interest
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/46—Ultrasonic, sonic or infrasonic diagnostic devices with special arrangements for interfacing with the operator or the patient
- A61B8/467—Ultrasonic, sonic or infrasonic diagnostic devices with special arrangements for interfacing with the operator or the patient characterised by special input means
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01S—RADIO DIRECTION-FINDING; RADIO NAVIGATION; DETERMINING DISTANCE OR VELOCITY BY USE OF RADIO WAVES; LOCATING OR PRESENCE-DETECTING BY USE OF THE REFLECTION OR RERADIATION OF RADIO WAVES; ANALOGOUS ARRANGEMENTS USING OTHER WAVES
- G01S15/00—Systems using the reflection or reradiation of acoustic waves, e.g. sonar systems
- G01S15/02—Systems using the reflection or reradiation of acoustic waves, e.g. sonar systems using reflection of acoustic waves
- G01S15/50—Systems of measurement, based on relative movement of the target
- G01S15/58—Velocity or trajectory determination systems; Sense-of-movement determination systems
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01S—RADIO DIRECTION-FINDING; RADIO NAVIGATION; DETERMINING DISTANCE OR VELOCITY BY USE OF RADIO WAVES; LOCATING OR PRESENCE-DETECTING BY USE OF THE REFLECTION OR RERADIATION OF RADIO WAVES; ANALOGOUS ARRANGEMENTS USING OTHER WAVES
- G01S7/00—Details of systems according to groups G01S13/00, G01S15/00, G01S17/00
- G01S7/52—Details of systems according to groups G01S13/00, G01S15/00, G01S17/00 of systems according to group G01S15/00
- G01S7/52017—Details of systems according to groups G01S13/00, G01S15/00, G01S17/00 of systems according to group G01S15/00 particularly adapted to short-range imaging
- G01S7/52079—Constructional features
- G01S7/52084—Constructional features related to particular user interfaces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/346—Analysis of electrocardiograms
- A61B5/349—Detecting specific parameters of the electrocardiograph cycle
- A61B5/352—Detecting R peaks, e.g. for synchronising diagnostic apparatus; Estimating R-R interval
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/54—Control of the diagnostic device
- A61B8/543—Control of the diagnostic device involving acquisition triggered by a physiological signal
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01S—RADIO DIRECTION-FINDING; RADIO NAVIGATION; DETERMINING DISTANCE OR VELOCITY BY USE OF RADIO WAVES; LOCATING OR PRESENCE-DETECTING BY USE OF THE REFLECTION OR RERADIATION OF RADIO WAVES; ANALOGOUS ARRANGEMENTS USING OTHER WAVES
- G01S15/00—Systems using the reflection or reradiation of acoustic waves, e.g. sonar systems
- G01S15/88—Sonar systems specially adapted for specific applications
- G01S15/89—Sonar systems specially adapted for specific applications for mapping or imaging
- G01S15/8906—Short-range imaging systems; Acoustic microscope systems using pulse-echo techniques
- G01S15/8979—Combined Doppler and pulse-echo imaging systems
Definitions
- This invention relates to medical diagnostic ultrasound systems and, in particular, to adjustable automated traces of spectral flow velocities.
- US patents 5,287,753 and 5,634,465 illustrate automated techniques for tracing the mean and peak velocity levels in a spectral Doppler display.
- the ultrasound systems in these patents process the Doppler data to identify the peak and/or the mean velocity for each spectral line. In both patents this is done in consideration of the possible contamination of the Doppler data with noise, in the former patent with reference to external noise sources and in the latter patent with reference to system noise sources.
- the mean and peak velocity levels are located in each spectral line as the line is produced, those points on the line can be identified visually as the spectral line is added to the scrolling spectral display and connected to the corresponding point or points on the previous spectral line. This enables the mean and/or peak velocity levels in the spectral display to be traced automatically in real time.
- the spectral display As the spectral display is produced it may be recorded and reviewed later for diagnosis or used for subsequent measurements or calculations of vascular performance.
- the automated traces will seem correct to the clinician, but occasionally a trace may seem incorrectly located on the spectral display.
- the clinician When the clinician is confronted with an automated trace which seems to the clinician to be intuitively inaccurate the only option is for the clinician to manually trace what he or she feels are the correct values in the spectral display.
- Such manual retracing of, for example, the peak velocity values can be laborious and time consuming.
- the clinician will generally resort to manual tracing in which he is confident, particularly when the traced levels are to be the basis for calculations of the patient's vascular performance. Accordingly it is desirable to provide some means for expediting the correction of an automated trace of a spectral display which seems incorrect to the user.
- a diagnostic ultrasound system and method which enables a user to adjust an automated spectral display trace which seems inaccurate to the user.
- a user control is provided by which the user can select a point or points on the automated spectral trace and relocate the point or points to a desired location on the spectral display.
- the automated system automatically repositions the trace including, when necessary, repositioning adjoining points of the trace.
- this manual adjustment of the trace is facilitated by showing control points on the trace at evenly spaced locations or at local minima and/or maxima in the trace.
- the manual adjustment is facilitated by showing key physiological points on the trace which the user may adjust in time position, velocity location, or both.
- the manual adjustment is facilitated by a local manual redraw of the trace which can start anywhere on the trace and be re-connected to another point on the trace at an ending point on the trace, updating any key physiological points on the redrawn trace.
- FIGURE 1 an ultrasound system constructed in accordance with the principles of the present invention is shown in block diagram form.
- Ultrasonic signals are transmitted by the array transducer 10 of an ultrasound probe and resultant echoes are received by transducer elements.
- the received echo signals are formed into a single signal or beam by a beamformer 14.
- the echo signal information is detected by a Doppler detector 16 which produces quadrature I and Q signal components.
- a number of such signal components from the site in the body being diagnosed are applied to a Doppler processor 18, one form of which is a fast Fourier transform (FFT) processor, which computes the Doppler frequency shift of the received signals.
- FFT fast Fourier transform
- This basic Doppler data is post-processed by a Doppler post processor 20, which further refines the data by techniques such as wall filtering, gain control, or amplitude compression.
- B mode echoes are received. These echoes are also formed into I and Q components which may then be amplitude detected by taking the square root of the sum of the squares of the I and Q values in a B mode image processor 64.
- the B mode image processor also arranges the B mode echoes into a desired display form by scan conversion.
- the resultant two dimensional image is coupled to a Doppler display processor 30 where it may be displayed in a time interleaved manner with the spectral Doppler data.
- the post processed Doppler data is applied to a peak velocity detector 58 and the Doppler display processor 30.
- the Doppler display processor uses the Doppler data for the display of a real time sequence of spectral line information.
- the peak velocity detector compares the Doppler data against a noise threshold NOISE th to determine the peak velocity point of a spectral line, as discussed more fully in US patents 5,287,753 and 5,634,465 .
- the peak velocity detector 22 may also perform filtering of the Doppler data and may also be used to identify mean velocity levels as discussed more fully in the '753 patent.
- the Doppler display processor 30 then provides both an anatomical B mode image and a spectral Doppler display with peak and/or mean velocity values automatically traced as the discussed in the aforementioned patents.
- the ultrasound display will also preferably show an ECG trace drawn in response to reception of an R-wave signal.
- the R-wave is the electrical physiological signal produced to stimulate the heart's contraction, and is conventionally detected by an electrocardiograph (ECG).
- FIGURE 1 shows a set of ECG electrodes 80 which may be affixed to the chest of a patient to detect the R-wave signal.
- the signal is detected and processed by an ECG signal processor 82 and applied to the Doppler display processor 30, which displays the ECG waveform in synchronism with the scrolling spectral Doppler display.
- the B mode image can be used to locate and display the point in the patient's anatomy at which the spectral information is acquired.
- FIGURE 2 A typical spectral Doppler display as produced by an embodiment of the present invention is shown in FIGURE 2 .
- Such a display generally comprises the Doppler information of discrete sampling periods displayed as a sequence of continuous scrolling spectral lines in a real time versus velocity display as shown in FIGURE 2 .
- newly generated spectral lines are continually produced at the right side of the display.
- the sequence of lines moves or scrolls from right to left, with previously generated spectral data on the left and progressively more current data to the right.
- Each line conveys the range of flow velocities detected in the blood flow at a chosen location in the body at a particular time of Doppler interrogation.
- the highest velocities shown by lines 100, 200, and 300 would typically occur during the systolic phase of the heart cycle.
- the intervals 12, 22, and 32 between the systolic phases represent flow velocity during the intervening diastolic phases of heart action.
- FIGURE 2 illustrates a spectral line display in which the peak velocity of each spectral (vertical) line has been identified and the peaks connected by the solid display line 60.
- the spectral line peak velocities can be identified and displayed as the spectral lines occur and are displayed, thereby providing a real time continuous display of traced peak spectral velocities.
- a mean velocity value is also calculated and displayed.
- the mean velocity is marked on the spectral line display, also concurrently with the initial appearance of the spectral line at the right-hand side of the spectral line display.
- FIGURE 2 shows a dashed line 62 which connects the calculated mean velocity values of the displayed spectral lines.
- the peak and mean velocity values may be traced with separately distinguished lines as shown in FIGURE 2 , or by differently colored lines.
- a preferred way to visually trace the peak and mean velocity values in a monochromatic high density spectral line display is shown in FIGURE 3 .
- the spectral lines 70 are displayed in shades of gray against a white background 72.
- the peak velocity line 80 is displayed as a sequence of black dots, each marking the peak velocity on its associated spectral line.
- the mean velocity values are marked by blanking the mean velocity positions on the respective spectral lines, thereby effectively leaving a white line running through the spectral lines 70 as indicated at 82.
- This technique takes advantage of rapid, high density production and display of spectral lines, in which the spectral lines 70 are displayed virtually adjacent to each other, thereby resembling a continuous band of gray shading below the peak velocity line 80.
- the white mean velocity line 82 is thus distinctly displayed in contrast to the surrounding gray shading of the spectral lines.
- FIGURE 3 is generally shown with black/white reversal in the typical ultrasound display.
- an automated tracing on a spectral display can be adjusted by the user as illustrated by FIGURES 4a-4c .
- the peak velocities of spectral lines 70 in FIGURE 4a have been traced by the line 80, corresponding to the peak velocity display line 60 in FIGURE 2 .
- the real time spectral display can be stopped (frozen) on the display screen by actuation of the "freeze" button on the ultrasound system control panel 99.
- a previously recorded real time spectral display can be replayed and frozen on the screen.
- the ultrasound system will automatically delineate the extent of the spectral lines of one heart cycle by vertical lines 92,94 known as "goalposts."
- the goalpost lines may be placed by examining the spectral waveform or trace for the end diastole minima.
- the goalpost lines may be located by relating the ECG trace to the spectral display when an ECG trace is available. The ultrasound system will then use the information of this heart cycle for calculations and measurements. If the user does not want to accept this heart cycle or prefers another, he may click on another heart cycle in the spectral display to reposition the goalpost lines 92,94, or drag the vertical goalpost lines with a screen cursor to frame a different heart cycle in the spectral display.
- the graphics on the lower left of the display show the numeric values of certain data points of the selected heart cycle and any calculations the user desires to see.
- the graphics show the peak systolic velocity (PSV) value of -58.9 cm/sec, the end diastolic velocity (EDV) value of -12.9 cm/sec, and the resistivity index (RI) of 0.78.
- the user feels that the trace 80 has been incorrectly drawn.
- the user may doubt the calculated RI value, for instance, which may lead to the belief that the trace 80 is not accurately drawn.
- the user clicks on the "Edit Trace" menu item which may be shown on the image display screen or on a touchscreen panel of the ultrasound system, or may be a separate control on the control panel 99.
- This selection will cause a series of control points 82,86 to appear on the trace 80 of the selected heart cycle, as shown in FIGURE 4b .
- the control points comprise a series of small markers 82 and larger markers 82', 82", and 86.
- the larger markers in this embodiment are located at key timing points of the heart cycle.
- the marker 82' marks the peak systolic velocity point on the trace 80
- the marker 82" marks the end systolic velocity point on the trace
- the marker 86 marks the end diastolic point on the trace.
- a cursor 84 which may be manipulated by a user control on the control panel 99 such as a trackball or mouse.
- the user feels that the peak systolic velocity point is actually higher than depicted by the automatically drawn trace 80.
- the user will then "grab" the control point 82' and "drag” it up to the desired velocity level as shown in FIGURE 4c .
- the trace 80 and other control points 82 on the trace follow along with the repositioned control point 82'. This is done by recalculating the trace 80 on-the-fly by a spline interpolation technique, whereby the relocation of one point on the trace causes neighboring points on connecting spline curves to be automatically adjusted to provide a smooth trace.
- control points 82,82' and trace 80 are repositioned by the user, display values and calculations associated with the trace are also updated and recalculated on-the-fly.
- the PSV value has been automatically updated to -89.8 cm/sec
- the location of the repositioned control point 82' in FIGURE 4c has been affected by the adjustment and recalculated to 0.86.
- the user can visually see the adjustment he is making to the automatic trace 80 and can simultaneously see the effects of his adjustment on displayed and calculated values.
- FIGURES 5a-5d illustrate a second embodiment of the present invention.
- the lines 70 of a spectral display have their peak velocity values traced by a trace line 80 and a heart cycle is delineated by the goalpost lines 92,94.
- the numeric display shows another key point in the spectral display, the mean diastole velocity (MDV).
- MDV mean diastole velocity
- Three other calculations are also displayed, the pulsatility index (PI), the systolic/diastolic ratio (S/D), and the time-averaged peak velocity (TAPV).
- PI pulsatility index
- S/D systolic/diastolic ratio
- TAPV time-averaged peak velocity
- the trace 80 has been supplemented with the addition of the display and identity of the key timing points of PSV, ESV, MDV, and EDV (end diastolic velocity).
- the key timing points to be displayed and identified can be chosen by the user and their location in time identified from the ECG waveform.
- the key timing points may also be calculated from the automatic tracing algorithm described in the aforementioned patents, which finds local maxima and minima as related to both the shape of the Doppler spectrum and the ECG waveform.
- the key timing points are displayed if the user chooses to show them (by turning them "on” via the control panel or user interface).
- the key timing points drive the results such as PSV, EDV and their derivative calculations.
- the PSV point is not located at the systolic peak of the tracing 80.
- the user may reposition the point along the trace ( i.e ., in time) by grabbing the PSV point with the screen cursor and sliding the PSV marker to the systolic peak of the trace 80 as shown in FIGURE 5c .
- the graphics are updated correspondingly. It can be seen that the PSV value has increased from -204 cm/sec to -272 cm/sec in this example, and that the dependent RI, PI and S/D calculations have changed also.
- the user may feel that the trace 80 is incorrectly drawn.
- the user may grab the trace 80 with a cursor 88 and drag the trace to the desired amplitude as shown in FIGURE 5d .
- the trace 80 is recalculated and display on-the-fly, giving the appearance that the user is stretching the trace line to its new location.
- the user may click at one point on the trace and redraw a portion of the trace manually with a screen pointer until reconnecting with the trace at another point on the trace. In this example the user has redrawn the spectral peak on either side of the cursor 88.
- the newly recalculated graphic values at the left of the display show that this repositioning of the peak velocity trace has affected three of the four displayed calculations.
- key points are automatically adjusted to their optimal locations based on the tracing algorithm.
- the user may reposition the key timing points on the trace manually. For instance, the PSV may be repositioned to the new systolic peak of the trace 80 in FIGURE 5d .
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Remote Sensing (AREA)
- Radar, Positioning & Navigation (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Radiology & Medical Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Computer Networks & Wireless Communication (AREA)
- General Physics & Mathematics (AREA)
- Acoustics & Sound (AREA)
- Hematology (AREA)
- Human Computer Interaction (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Radar Systems Or Details Thereof (AREA)
Abstract
Description
- This invention relates to medical diagnostic ultrasound systems and, in particular, to adjustable automated traces of spectral flow velocities.
-
US patents 5,287,753 and5,634,465 illustrate automated techniques for tracing the mean and peak velocity levels in a spectral Doppler display. As each spectral line for the spectral Display is created, the ultrasound systems in these patents process the Doppler data to identify the peak and/or the mean velocity for each spectral line. In both patents this is done in consideration of the possible contamination of the Doppler data with noise, in the former patent with reference to external noise sources and in the latter patent with reference to system noise sources. When the mean and peak velocity levels are located in each spectral line as the line is produced, those points on the line can be identified visually as the spectral line is added to the scrolling spectral display and connected to the corresponding point or points on the previous spectral line. This enables the mean and/or peak velocity levels in the spectral display to be traced automatically in real time. - As the spectral display is produced it may be recorded and reviewed later for diagnosis or used for subsequent measurements or calculations of vascular performance. Usually the automated traces will seem correct to the clinician, but occasionally a trace may seem incorrectly located on the spectral display. When the clinician is confronted with an automated trace which seems to the clinician to be intuitively inaccurate the only option is for the clinician to manually trace what he or she feels are the correct values in the spectral display. Such manual retracing of, for example, the peak velocity values can be laborious and time consuming. However the clinician will generally resort to manual tracing in which he is confident, particularly when the traced levels are to be the basis for calculations of the patient's vascular performance. Accordingly it is desirable to provide some means for expediting the correction of an automated trace of a spectral display which seems incorrect to the user.
- In accordance with the principles of the present invention, a diagnostic ultrasound system and method are described which enables a user to adjust an automated spectral display trace which seems inaccurate to the user. A user control is provided by which the user can select a point or points on the automated spectral trace and relocate the point or points to a desired location on the spectral display. As the point or points are manually relocated by the user the automated system automatically repositions the trace including, when necessary, repositioning adjoining points of the trace. In one embodiment this manual adjustment of the trace is facilitated by showing control points on the trace at evenly spaced locations or at local minima and/or maxima in the trace. In another embodiment the manual adjustment is facilitated by showing key physiological points on the trace which the user may adjust in time position, velocity location, or both. In another embodiment the manual adjustment is facilitated by a local manual redraw of the trace which can start anywhere on the trace and be re-connected to another point on the trace at an ending point on the trace, updating any key physiological points on the redrawn trace.
- In the drawings:
-
FIGURE 1 illustrates in block diagram form an ultrasonic diagnostic imaging system constructed in accordance with the principles of the present invention; -
FIGURE 2 illustrates a spectral Doppler display in which both the peak and mean velocity levels have been traced; -
FIGURE 3 illustrates a preferred technique for tracing the peak and mean velocity levels in a high line density spectral display; -
FIGURES 4a ,4b , and4c illustrate a first embodiment of the present invention by which an automated spectral Doppler trace may be manually adjusted; and -
FIGURES 5a ,5b ,5c and5d illustrate a second embodiment of the present invention by which key points in a spectral Doppler trace are identified and adjusted. - Referring first to
FIGURE 1 , an ultrasound system constructed in accordance with the principles of the present invention is shown in block diagram form. Ultrasonic signals are transmitted by thearray transducer 10 of an ultrasound probe and resultant echoes are received by transducer elements. The received echo signals are formed into a single signal or beam by abeamformer 14. The echo signal information is detected by aDoppler detector 16 which produces quadrature I and Q signal components. A number of such signal components from the site in the body being diagnosed are applied to a Dopplerprocessor 18, one form of which is a fast Fourier transform (FFT) processor, which computes the Doppler frequency shift of the received signals. This basic Doppler data is post-processed by a Dopplerpost processor 20, which further refines the data by techniques such as wall filtering, gain control, or amplitude compression. - Intermittently during the reception of Doppler echoes, B mode echoes are received. These echoes are also formed into I and Q components which may then be amplitude detected by taking the square root of the sum of the squares of the I and Q values in a B
mode image processor 64. The B mode image processor also arranges the B mode echoes into a desired display form by scan conversion. The resultant two dimensional image is coupled to a Dopplerdisplay processor 30 where it may be displayed in a time interleaved manner with the spectral Doppler data. - The post processed Doppler data is applied to a
peak velocity detector 58 and the Dopplerdisplay processor 30. The Doppler display processor uses the Doppler data for the display of a real time sequence of spectral line information. The peak velocity detector compares the Doppler data against a noise threshold NOISEth to determine the peak velocity point of a spectral line, as discussed more fully inUS patents 5,287,753 and5,634,465 . Thepeak velocity detector 22 may also perform filtering of the Doppler data and may also be used to identify mean velocity levels as discussed more fully in the '753 patent. The Dopplerdisplay processor 30 then provides both an anatomical B mode image and a spectral Doppler display with peak and/or mean velocity values automatically traced as the discussed in the aforementioned patents. - The ultrasound display will also preferably show an ECG trace drawn in response to reception of an R-wave signal. The R-wave is the electrical physiological signal produced to stimulate the heart's contraction, and is conventionally detected by an electrocardiograph (ECG).
FIGURE 1 shows a set ofECG electrodes 80 which may be affixed to the chest of a patient to detect the R-wave signal. The signal is detected and processed by anECG signal processor 82 and applied to the Dopplerdisplay processor 30, which displays the ECG waveform in synchronism with the scrolling spectral Doppler display. The B mode image can be used to locate and display the point in the patient's anatomy at which the spectral information is acquired. - A typical spectral Doppler display as produced by an embodiment of the present invention is shown in
FIGURE 2 . Such a display generally comprises the Doppler information of discrete sampling periods displayed as a sequence of continuous scrolling spectral lines in a real time versus velocity display as shown inFIGURE 2 . In the display ofFIGURE 2 , newly generated spectral lines are continually produced at the right side of the display. The sequence of lines moves or scrolls from right to left, with previously generated spectral data on the left and progressively more current data to the right. Each line conveys the range of flow velocities detected in the blood flow at a chosen location in the body at a particular time of Doppler interrogation. The highest velocities shown bylines intervals - In accordance with the principles of the present invention,
FIGURE 2 illustrates a spectral line display in which the peak velocity of each spectral (vertical) line has been identified and the peaks connected by thesolid display line 60. AsFIGURE 2 shows, the spectral line peak velocities can be identified and displayed as the spectral lines occur and are displayed, thereby providing a real time continuous display of traced peak spectral velocities. For each displayed spectral line which satisfies a noise immunity test a mean velocity value is also calculated and displayed. A variety of techniques are known for calculating mean velocity as discussed in the aforementioned '753 patent. The mean velocity is marked on the spectral line display, also concurrently with the initial appearance of the spectral line at the right-hand side of the spectral line display.FIGURE 2 shows adashed line 62 which connects the calculated mean velocity values of the displayed spectral lines. - The peak and mean velocity values may be traced with separately distinguished lines as shown in
FIGURE 2 , or by differently colored lines. A preferred way to visually trace the peak and mean velocity values in a monochromatic high density spectral line display is shown inFIGURE 3 . In this FIGURE thespectral lines 70 are displayed in shades of gray against awhite background 72. Thepeak velocity line 80 is displayed as a sequence of black dots, each marking the peak velocity on its associated spectral line. The mean velocity values are marked by blanking the mean velocity positions on the respective spectral lines, thereby effectively leaving a white line running through thespectral lines 70 as indicated at 82. This technique takes advantage of rapid, high density production and display of spectral lines, in which thespectral lines 70 are displayed virtually adjacent to each other, thereby resembling a continuous band of gray shading below thepeak velocity line 80. The whitemean velocity line 82 is thus distinctly displayed in contrast to the surrounding gray shading of the spectral lines. One skilled in the art will realize that the display ofFIGURE 3 is generally shown with black/white reversal in the typical ultrasound display. - In accordance with the principles of the present invention, an automated tracing on a spectral display can be adjusted by the user as illustrated by
FIGURES 4a-4c . In this first embodiment the peak velocities ofspectral lines 70 inFIGURE 4a have been traced by theline 80, corresponding to the peakvelocity display line 60 inFIGURE 2 . The real time spectral display can be stopped (frozen) on the display screen by actuation of the "freeze" button on the ultrasoundsystem control panel 99. Alternatively, a previously recorded real time spectral display can be replayed and frozen on the screen. In either case, the ultrasound system will automatically delineate the extent of the spectral lines of one heart cycle byvertical lines - However, suppose that the user feels that the
trace 80 has been incorrectly drawn. The user may doubt the calculated RI value, for instance, which may lead to the belief that thetrace 80 is not accurately drawn. In such case, the user clicks on the "Edit Trace" menu item, which may be shown on the image display screen or on a touchscreen panel of the ultrasound system, or may be a separate control on thecontrol panel 99. This selection will cause a series of control points 82,86 to appear on thetrace 80 of the selected heart cycle, as shown inFIGURE 4b . In this embodiment the control points comprise a series ofsmall markers 82 andlarger markers 82', 82", and 86. The larger markers in this embodiment are located at key timing points of the heart cycle. In this case the marker 82' marks the peak systolic velocity point on thetrace 80, themarker 82" marks the end systolic velocity point on the trace, and themarker 86 marks the end diastolic point on the trace. Also appearing on the screen is acursor 84 which may be manipulated by a user control on thecontrol panel 99 such as a trackball or mouse. - In this example the user feels that the peak systolic velocity point is actually higher than depicted by the automatically drawn
trace 80. The user will then "grab" the control point 82' and "drag" it up to the desired velocity level as shown inFIGURE 4c . As the control point 82' is repositioned, thetrace 80 and other control points 82 on the trace follow along with the repositioned control point 82'. This is done by recalculating thetrace 80 on-the-fly by a spline interpolation technique, whereby the relocation of one point on the trace causes neighboring points on connecting spline curves to be automatically adjusted to provide a smooth trace. As the control points 82,82' and trace 80 are repositioned by the user, display values and calculations associated with the trace are also updated and recalculated on-the-fly. In this example it can be seen that the PSV value has been automatically updated to -89.8 cm/sec, the location of the repositioned control point 82' inFIGURE 4c , and the RI value has been affected by the adjustment and recalculated to 0.86. Thus, the user can visually see the adjustment he is making to theautomatic trace 80 and can simultaneously see the effects of his adjustment on displayed and calculated values. These new display and calculated values can give the user confidence in the accuracy of his adjustments or lead to their further refinement by subsequent adjustment. -
FIGURES 5a-5d illustrate a second embodiment of the present invention. InFIGURE 5a thelines 70 of a spectral display have their peak velocity values traced by atrace line 80 and a heart cycle is delineated by the goalpost lines 92,94. The numeric display shows another key point in the spectral display, the mean diastole velocity (MDV). Three other calculations are also displayed, the pulsatility index (PI), the systolic/diastolic ratio (S/D), and the time-averaged peak velocity (TAPV). - In
FIGURE 5b thetrace 80 has been supplemented with the addition of the display and identity of the key timing points of PSV, ESV, MDV, and EDV (end diastolic velocity). The key timing points to be displayed and identified can be chosen by the user and their location in time identified from the ECG waveform. The key timing points may also be calculated from the automatic tracing algorithm described in the aforementioned patents, which finds local maxima and minima as related to both the shape of the Doppler spectrum and the ECG waveform. The key timing points are displayed if the user chooses to show them (by turning them "on" via the control panel or user interface). The key timing points drive the results such as PSV, EDV and their derivative calculations. In this example it is seen that the PSV point is not located at the systolic peak of the tracing 80. In such case the user may reposition the point along the trace (i.e., in time) by grabbing the PSV point with the screen cursor and sliding the PSV marker to the systolic peak of thetrace 80 as shown inFIGURE 5c . The graphics are updated correspondingly. It can be seen that the PSV value has increased from -204 cm/sec to -272 cm/sec in this example, and that the dependent RI, PI and S/D calculations have changed also. - Alternatively or additionally, the user may feel that the
trace 80 is incorrectly drawn. In such case the user may grab thetrace 80 with acursor 88 and drag the trace to the desired amplitude as shown inFIGURE 5d . As in the previous example, thetrace 80 is recalculated and display on-the-fly, giving the appearance that the user is stretching the trace line to its new location. Alternatively, the user may click at one point on the trace and redraw a portion of the trace manually with a screen pointer until reconnecting with the trace at another point on the trace. In this example the user has redrawn the spectral peak on either side of thecursor 88. The newly recalculated graphic values at the left of the display show that this repositioning of the peak velocity trace has affected three of the four displayed calculations. In this embodiment there are no discrete control points for the user to grab. Instead, each point on thetrace 80 may be grabbed and repositioned by the user's cursor to adjust the position of the automated spectral trace. Following the adjustment of thetrace 80, key points are automatically adjusted to their optimal locations based on the tracing algorithm. However, if the automatic placement of the key points is deemed unsatisfactory, the user may reposition the key timing points on the trace manually. For instance, the PSV may be repositioned to the new systolic peak of thetrace 80 inFIGURE 5d .
Claims (20)
- An ultrasonic diagnostic imaging system for analyzing blood flow comprising:means (10, 14) for acquiring spectral Doppler information;a spectral Doppler analyze (16, 18, 20, 30, 58), responsive to the spectral Doppler information, which automatically traces at least one of the mean or peak velocity of a flow spectrum;a display (32), coupled to the spectral Doppler analyzer, which displays the Doppler flow spectrum (70) with the tracer (80); anda user control, operable with the display, by which the position of the trace relative to the Doppler flow spectrum may be manually adjusted.
- The ultrasonic diagnostic imaging system of Claim 1, wherein the trace further includes a plurality of control points (82, 86) by which the position of the trace may be adjusted by operation of the user control.
- The ultrasonic diagnostic imaging system of Claim 2, wherein the control points are uniformly distributed in time along the trace.
- The ultrasonic diagnostic imaging system of Claim 2, wherein the control points are located at local minima and/or maxima of the trace.
- The ultrasonic diagnostic imaging system of Claim 2, wherein the control points are located at key timing points of the heart cycle.
- The ultrasonic diagnostic imaging system of Claim 5, wherein the control points are graphically identified on the display.
- The ultrasonic diagnostic imaging system of Claim 5, wherein the Doppler flow spectrum has a velocity axis and a time axis; and
wherein the control points are adjustable in both the time and velocity dimensions. - The ultrasonic diagnostic imaging system of Claim 1, wherein the display further displays a trace adjustment cursor (84),
wherein the trace adjustment cursor is operable by the user control to adjust the position of the trace. - The ultrasonic diagnostic imaging system of Claim 8, wherein the trace adjustment cursor is operable by the user control to adjust the velocity position of the trace.
- The ultrasonic diagnostic imaging system of Claim 8, wherein the trace further includes a plurality of control points; and
wherein the trace adjustment cursor is operable by the user control to adjust the position of a control point along the trace. - The ultrasonic diagnostic imaging system of Claim 10, wherein the control points define key timing points of the heart cycle.
- The ultrasonic diagnostic imaging system of Claim 1, wherein the spectral Doppler analyzer further comprises means for delineating a heart cycle of a Doppler flow spectrum from which key values or calculations can be produced.
- The ultrasonic diagnostic imaging system of Claim 12, wherein the display further comprises means for graphically displaying key values and/or calculations from a delineated heart cycle.
- The ultrasonic diagnostic imaging system of Claim 13, wherein the spectral Doppler analyzer further comprises means for automatically updating a graphically displayed key value and/or calculation of a delineated heart cycle in response to adjustment of the position of the trace.
- A method for adjusting an automatically drawn trace (80) of a spectral Doppler parameter comprising :displaying a Doppler flow spectrum (70) on which a parameter has been traced (80);grabbing a point on the trace with a display cursor (84) manipulated by a user control (99); anddragging the point on the trace to a different position on the display (32).
- The method of Claim 15, wherein grabbing further comprises grabbing a control point on the trace.
- The method of Claim 16, wherein dragging further comprises moving the control point to a different position in time and/or velocity on the display.
- The method of Claim 15, further comprising automatically fitting the trace on either side of the point to the different position of the point on the display.
- The method of Claim 15, wherein grabbing further comprises grabbing a point on the trace defined as a key timing point of the heart cycle.
- The method of Claim 15, further comprising displaying graphics of key value and/or calculation based upon the trace of a heart cycle,
wherein a graphically displayed key value and/or calculation is automatically updated in response to dragging a point on the trace to a different position.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60563604P | 2004-08-30 | 2004-08-30 | |
PCT/IB2005/052572 WO2006024975A1 (en) | 2004-08-30 | 2005-08-01 | Adjustable tracing of flow velocities in doppler velocity spectra |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1797455A1 EP1797455A1 (en) | 2007-06-20 |
EP1797455B1 true EP1797455B1 (en) | 2009-07-08 |
Family
ID=35276103
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20050776023 Active EP1797455B1 (en) | 2004-08-30 | 2005-08-01 | Adjustable tracing of flow velocities in doppler velocity spectra |
Country Status (8)
Country | Link |
---|---|
US (1) | US20080039725A1 (en) |
EP (1) | EP1797455B1 (en) |
JP (1) | JP2008511367A (en) |
KR (1) | KR20070046889A (en) |
CN (1) | CN100587517C (en) |
AT (1) | ATE436032T1 (en) |
DE (1) | DE602005015345D1 (en) |
WO (1) | WO2006024975A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1977767B (en) * | 2005-12-08 | 2010-10-06 | 深圳迈瑞生物医疗电子股份有限公司 | Method for improving respiratory wave identification rate |
FR2906451A1 (en) * | 2006-10-03 | 2008-04-04 | Jean Pierre Patrier | Approach`s functioning monitoring apparatus for e.g. hemodialysis of infant, has Doppler probe to measure diastolic speed and connected to Doppler apparatus with graph displaying zones that represent functioning state of approach |
JP5085170B2 (en) * | 2007-03-28 | 2012-11-28 | 株式会社東芝 | Ultrasonic diagnostic equipment |
CN103431876B (en) * | 2008-12-02 | 2015-08-05 | 株式会社东芝 | Diagnostic ultrasound equipment, doppler measuring apparatus and Doppler measurement method |
JP2011025011A (en) * | 2009-06-26 | 2011-02-10 | Toshiba Corp | Ultrasonic diagnosis apparatus and ultrasonic diagnosis apparatus control program |
EP2670309B1 (en) | 2011-02-03 | 2018-10-24 | Yoram Palti | Transthoracic cardio-pulmonary monitor |
CN104684488B (en) | 2012-09-27 | 2017-08-15 | 皇家飞利浦有限公司 | Automatic biplane PW workflows for ultrasonic stenosis assessment |
EP4011298A1 (en) | 2014-11-18 | 2022-06-15 | C. R. Bard, Inc. | Ultrasound imaging system having automatic image presentation |
EP3220828B1 (en) | 2014-11-18 | 2021-12-22 | C.R. Bard, Inc. | Ultrasound imaging system having automatic image presentation |
JP6584906B2 (en) * | 2015-10-15 | 2019-10-02 | キヤノンメディカルシステムズ株式会社 | Ultrasonic diagnostic apparatus and medical image processing apparatus |
KR102447020B1 (en) * | 2016-09-20 | 2022-09-26 | 삼성메디슨 주식회사 | Apparatus and method for displaying ultrasound image |
US20180344292A1 (en) * | 2017-05-31 | 2018-12-06 | General Electric Company | Methods and system for automatically analyzing a doppler spectrum |
US11779311B2 (en) * | 2018-09-14 | 2023-10-10 | Fujifilm Sonosite, Inc. | Method and apparatus for performing spectral doppler imaging |
CN110786883B (en) * | 2019-11-06 | 2022-05-27 | 深圳开立生物医疗科技股份有限公司 | Method and device for generating spectrum envelope curve, ultrasonic equipment and storage medium |
JP2023135682A (en) * | 2022-03-16 | 2023-09-29 | 富士フイルムヘルスケア株式会社 | Ultrasonic diagnostic device and electrocardiographic waveform processing method |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3693264B2 (en) * | 1994-12-27 | 2005-09-07 | 東芝医用システムエンジニアリング株式会社 | Ultrasonic diagnostic equipment |
JP2956534B2 (en) * | 1995-06-05 | 1999-10-04 | 松下電器産業株式会社 | Ultrasound Doppler blood flow meter |
US5634465A (en) * | 1995-06-09 | 1997-06-03 | Advanced Technology Laboratories, Inc. | Continuous display of cardiac blood flow information |
JP3892538B2 (en) * | 1997-07-18 | 2007-03-14 | 株式会社東芝 | Ultrasonic Doppler diagnostic device |
JP4240633B2 (en) * | 1999-02-10 | 2009-03-18 | 株式会社東芝 | Ultrasonic Doppler diagnostic device |
US6464637B1 (en) * | 2000-06-23 | 2002-10-15 | Koninklijke Philips Electronics N.V. | Automatic flow angle correction by ultrasonic vector |
US6537221B2 (en) * | 2000-12-07 | 2003-03-25 | Koninklijke Philips Electronics, N.V. | Strain rate analysis in ultrasonic diagnostic images |
JP4094317B2 (en) * | 2002-03-28 | 2008-06-04 | 株式会社東芝 | Ultrasonic diagnostic equipment |
JP4085315B2 (en) * | 2002-09-27 | 2008-05-14 | 株式会社日立メディコ | Medical diagnostic imaging equipment |
-
2005
- 2005-08-01 WO PCT/IB2005/052572 patent/WO2006024975A1/en active Application Filing
- 2005-08-01 CN CN200580029233A patent/CN100587517C/en active Active
- 2005-08-01 DE DE200560015345 patent/DE602005015345D1/en active Active
- 2005-08-01 AT AT05776023T patent/ATE436032T1/en not_active IP Right Cessation
- 2005-08-01 KR KR20077004500A patent/KR20070046889A/en not_active Application Discontinuation
- 2005-08-01 JP JP2007529055A patent/JP2008511367A/en active Pending
- 2005-08-01 EP EP20050776023 patent/EP1797455B1/en active Active
- 2005-08-01 US US11/573,806 patent/US20080039725A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN101010599A (en) | 2007-08-01 |
US20080039725A1 (en) | 2008-02-14 |
WO2006024975A1 (en) | 2006-03-09 |
KR20070046889A (en) | 2007-05-03 |
ATE436032T1 (en) | 2009-07-15 |
EP1797455A1 (en) | 2007-06-20 |
CN100587517C (en) | 2010-02-03 |
JP2008511367A (en) | 2008-04-17 |
DE602005015345D1 (en) | 2009-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1797455B1 (en) | Adjustable tracing of flow velocities in doppler velocity spectra | |
US6863655B2 (en) | Ultrasound display of tissue, tracking and tagging | |
US11331076B2 (en) | Method and system for displaying ultrasonic elastic measurement | |
US9662088B2 (en) | Ultrasound pulse-wave doppler measurement of blood flow velocity and/or turbulence | |
US6592522B2 (en) | Ultrasound display of displacement | |
JP2008511367A5 (en) | ||
US11510651B2 (en) | Ultrasonic diagnosis of cardiac performance using heart model chamber segmentation with user control | |
US20040249281A1 (en) | Method and apparatus for extracting wall function information relative to ultrasound-located landmarks | |
US20070167771A1 (en) | Ultrasound location of anatomical landmarks | |
US20060058610A1 (en) | Increasing the efficiency of quantitation in stress echo | |
US20100234731A1 (en) | Automatic Ultrasonic Doppler Measurements | |
US20060058674A1 (en) | Optimizing ultrasound acquisition based on ultrasound-located landmarks | |
US20040249282A1 (en) | System and method for extracting information based on ultrasound-located landmarks | |
US6652462B2 (en) | Ultrasound display of movement parameter gradients | |
US20080051661A1 (en) | Ultrasonic diagnostic apparatus and ultrasonic diagnostic method | |
EP3267896B1 (en) | Ultrasonic diagnosis of cardiac performance by single degree of freedom chamber segmentation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20070330 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
DAX | Request for extension of the european patent (deleted) | ||
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REF | Corresponds to: |
Ref document number: 602005015345 Country of ref document: DE Date of ref document: 20090820 Kind code of ref document: P |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090708 |
|
NLV1 | Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act | ||
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20091108 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20091019 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090708 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090708 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090708 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090708 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090708 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090708 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20091109 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20091008 Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090831 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090831 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090708 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090831 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090708 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090708 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090708 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090708 Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090708 |
|
26N | No opposition filed |
Effective date: 20100409 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090801 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20091009 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090708 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090801 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100109 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090708 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090708 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090708 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R082 Ref document number: 602005015345 Country of ref document: DE Representative=s name: VOLMER, GEORG, DIPL.-ING., DE |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R082 Ref document number: 602005015345 Country of ref document: DE Representative=s name: VOLMER, GEORG, DIPL.-ING., DE Effective date: 20140331 Ref country code: DE Ref legal event code: R081 Ref document number: 602005015345 Country of ref document: DE Owner name: KONINKLIJKE PHILIPS N.V., NL Free format text: FORMER OWNER: KONINKLIJKE PHILIPS ELECTRONICS N.V., EINDHOVEN, NL Effective date: 20140331 Ref country code: DE Ref legal event code: R082 Ref document number: 602005015345 Country of ref document: DE Representative=s name: MEISSNER BOLTE PATENTANWAELTE RECHTSANWAELTE P, DE Effective date: 20140331 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: CD Owner name: KONINKLIJKE PHILIPS N.V., NL Effective date: 20141126 Ref country code: FR Ref legal event code: CA Effective date: 20141126 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 12 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R082 Ref document number: 602005015345 Country of ref document: DE Representative=s name: MEISSNER BOLTE PATENTANWAELTE RECHTSANWAELTE P, DE |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 13 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 14 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20230824 Year of fee payment: 19 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R084 Ref document number: 602005015345 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: 746 Effective date: 20240912 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240828 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20240827 Year of fee payment: 20 |